Literature DB >> 22784546

A review on the clinical spectrum and natural history of human influenza.

Warunee Punpanich1, Tawee Chotpitayasunondh.   

Abstract

OBJECTIVES: The objective of this review is to provide updated information on the clinical spectrum and natural history of human influenza, including risk factors for severe disease, and to identify the knowledge gap in this area.
METHODS: We searched the MEDLINE database of the recent literature for the period January 2009 to August 17, 2011 with regard to the abovementioned aspects of human influenza, focusing on A(H1N1)pdm09 and seasonal influenza.
RESULTS: The clinical spectrum and outcomes of cases of A(H1N1)pdm09 influenza have been mild and rather indistinguishable from those of seasonal influenza. Sporadic cases covering a wide range of neurological complications have been reported. Underlying predisposing conditions considered to be high-risk for A(H1N1)pdm09 infections are generally similar to those of seasonal influenza, but with two additional risk groups: pregnant women and the morbidly obese. Co-infections with bacteria and D222/N variants or 225G substitution of the viral genome have also been reported to be significant factors associated with the severity of disease. The current knowledge gap includes: (1) a lack of clarification regarding the relatively greater severity of the Mexican A(H1N1)pdm09 influenza outbreak in the early phase of the pandemic; (2) insufficient data on the clinical impact, risk factors, and outcomes of human infections caused by resistant strains of influenza; and (3) insufficient data from less developed countries that would enable them to prioritize strategies for influenza prevention and control.
CONCLUSIONS: Clinical features and risk factors of A(H1N1)pdm09 are comparable to those of seasonal influenza. Emerging risk factors for severe disease with A(H1N1)pdm09 include morbid obesity, pregnancy, bacterial co-infections, and D222/N variants or 225G substitution of the viral genome.
Copyright © 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22784546     DOI: 10.1016/j.ijid.2012.05.1025

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  23 in total

1.  Making progress on the WHO Public Health Research Agenda for Influenza.

Authors:  Nahoko Shindo
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

2.  Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses.

Authors:  Louise A Carolan; Steve Rockman; Kathryn Borg; Teagan Guarnaccia; Patrick Reading; Jennifer Mosse; Anne Kelso; Ian Barr; Karen L Laurie
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 3.  Review Article: The Fraction of Influenza Virus Infections That Are Asymptomatic: A Systematic Review and Meta-analysis.

Authors:  Nancy H L Leung; Cuiling Xu; Dennis K M Ip; Benjamin J Cowling
Journal:  Epidemiology       Date:  2015-11       Impact factor: 4.822

Review 4.  A Review on Equine Influenza from a Human Influenza Perspective.

Authors:  Fleur Whitlock; Pablo R Murcia; J Richard Newton
Journal:  Viruses       Date:  2022-06-15       Impact factor: 5.818

5.  Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice.

Authors:  Yipeng Sun; Qi Xu; Ye Shen; Linqing Liu; Kai Wei; Honglei Sun; Juan Pu; Kin-Chow Chang; Jinhua Liu
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

6.  The role of initial radiologic and clinical manifestations in predicting the prognosis for pneumonia caused by H1N1 influenza virus.

Authors:  Cemil Göya; Alpaslan Yavuz; Cihad Hamidi; Mehmet Güli Cetinçakmak; Memik Teke; Salih Hattapoğlu; Abdurrahim Duşak
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

7.  Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections.

Authors:  Alexandria D Tricoche; Abram L Wagner; Angel Balmaseda; Nery Sanchez; Mayuri Patel; Roger Lopez; Amy Schiller; Sergio Ojeda; Aaron M Frutos; Guillermina Kuan; Aubree Gordon
Journal:  J Infect Dis       Date:  2021-03-03       Impact factor: 5.226

8.  Use of linked electronic health records to assess mortality and length of stay associated with pandemic influenza A(H1N1)pdm09 at a UK teaching hospital.

Authors:  C Smith; M D Curran; I Roddick; M Reacher
Journal:  Epidemiol Infect       Date:  2014-08-14       Impact factor: 2.451

9.  Characteristics and outcomes of family-practice patients with coronavirus disease 2019: a case series.

Authors:  Stefania Dzieciolowska; Oumeet Ravi; Roland Grad
Journal:  J Med Case Rep       Date:  2021-07-20

10.  Mass spectrometry analysis coupled with de novo sequencing reveals amino acid substitutions in nucleocapsid protein from influenza A virus.

Authors:  Zijian Li; Wanchun Sun; Donglin Wu; Xiang Gao; Ningning Sun; Ning Liu
Journal:  Int J Mol Sci       Date:  2014-02-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.